Fludarabine and cytosine-arabinoside for poor-risk acute myeloid leukemia

Haematologica

Volumn 83, Issue 3, 1998, Pages 281-288

  Russo, D ^a   Candoni, A ^a   Grattoni, R ^a   Bertone, A ^a   Zaja, F ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Acute myeloid leukemia; Cytosine arabinoside; Fludarabine; Treatment

Indexed keywords

CYTARABINE; FLUDARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RISK; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; FEMALE; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; REMISSION INDUCTION; RISK FACTORS; TIME FACTORS; VIDARABINE;

EID: 0031960387     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)